跳至主要内容
临床试验/EUCTR2018-004370-96-DK
EUCTR2018-004370-96-DK进行中(未招募)1 期

The effects of topical corticosteroid use on insulin sensitivity and bone turnover

Jacob Pontoppidan Thyssen0 个研究点目标入组 36 人开始时间: 2018年12月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion criteria
  • Age 18–75 years
  • AD according to the Hanifin and Rajka Criteria22
  • AD for at least 3 years
  • BMI = 30 kg/m2
  • Haemoglobin A1c (HbA1c) = 42 mmol/mol (6.0%)
  • Normal haemoglobin
  • Informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 36
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria
  • Diagnosed diabetes mellitus
  • Other chronic inflammatory diseases (including but not limited to rheumatoid arthritis, inflammatory bowel disease etc) beside AD and non-treatment demanding rhinitis or asthma (treated within the last 4 weeks)
  • Pregnancy or breast feeding
  • Treatment with drugs that might affect the glucose metabolism beside TCS within a month prior to the project
  • Daily smoker, alcoholic, or drug abuser

研究者

发起方
Jacob Pontoppidan Thyssen

相似试验